Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
113 studies found for:    Open Studies | "Thrombocytopenia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Condition: Thrombocytopenia
Intervention: Drug: Eltrombopag
2 Recruiting American Trial Using Tranexamic Acid in Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
3 Recruiting A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Conditions: Alloimmune Thrombocytopenia;   Fetal Alloimmune Thrombocytopenia
Intervention: Drug: IVIG (Intravenous Immunoglobulin)
4 Recruiting Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Condition: Neonatal Thrombocytopenia
Intervention:
5 Recruiting The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study
Condition: Thrombocytopenia
Intervention:
6 Not yet recruiting Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic
Condition: Thrombocytopenia
Intervention: Biological: blood sample
7 Not yet recruiting A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Bortezomib
8 Recruiting Study of PRTX-100 in Adult Patients With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100
9 Recruiting A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Decitabine
10 Recruiting Open-Label, Dose Escalation Study of PRTX-100 in Adults With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100
11 Recruiting Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Probiotic Agent;   Drug: Dexamethasone
12 Recruiting Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
Condition: Thrombocytopenia
Intervention: Drug: recombinant human thrombopoietin
13 Recruiting Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Condition: Thrombocytopenia
Interventions: Drug: Hydroxychloroquine;   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
14 Recruiting Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
Condition: Isolated Chemotherapy-induced Thrombocytopenia
Intervention: Biological: romiplostim
15 Recruiting Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Romiplostin
16 Recruiting End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Discontinuation of eltrombopag
17 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
18 Recruiting Pharmacogenomics of Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Procedure: Blood Draw
19 Not yet recruiting Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Condition: Neonatal Alloimmune Thrombocytopenia
Intervention: Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
20 Recruiting Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
Condition: Thrombocytopenia
Intervention: Drug: UCB7665

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.